-
Search Underway for 'Dooars Rani' Tigress After Second Escape from Buxa Tiger Reserve
-
Best Pet Advent Calendars for Christmas 2026: Dog Treats and Cat Toys
-
IIM Indore Announces IPMAT 2027 Exam Date for April 24
-
Grattan Institute Releases Blueprint to Target Specialists Over Excessive Fees
-
The Dilemma of Recording Live Music: Preserving Memories vs. Being Present
-
Arizona Science Center Hosts Girls in STEM Astro Adventures for Students
-
ANC’s Renewal Rhetoric Fades as Voters Reject Party in 2026 Local Elections
-
New Turkish Cafe, Japanese BBQ, and Korean Restaurants Open Across East Bay
-
Foreign Investors Return to Indian Markets After 10-Month Selloff
-
Knowle Move Four Points Clear at Top After Histon Victory
-
Honda CR-V and Toyota RAV4 Lead Canada’s Most Stolen Vehicles List for 2025
Roche says will invest $50 bn in US over next five years
Swiss pharmaceutical giant Roche on Tuesday announced plans to invest $50 billion in the United States over the next five years.
"These investments further strengthen Roche's already significant US footprint with 13 manufacturing and 15 R&D sites across the pharmaceutical and diagnostics divisions, and are expected to create more than 12,000 new jobs," a company statement said.
The firm already has plants in the United States, and said the move would help expand capacity at sites in Kentucky, Indiana, New Jersey, Oregon and California.
"Today’s announced investments underscore our long-standing commitment to research, development and manufacturing in the US," said Roche Group chief executive Thomas Schinecker.
"Our investments of $50 billion over the next five years will lay the foundation for our next era of innovation and growth, benefiting patients in the US and around the world."
E.Raimundo--PC